Evidence map›Paper›PMID 30364544›Full record

ArticleOpen heart

Survival in patients with univentricular hearts: the impact of right versus left ventricular morphology.

Gunnar Erikssen, Jamil Aboulhosn, Jeannette Lin, Knut Liestøl, Mette E Estensen, Ola Gjesdal, Helge Skulstad, Gaute Døhlen, Harald Lauritz Lindberg

Abstract read
In one paragraph

Article in Open heart. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The pathophysiology and complications of Fontan circulation.Acta bio-medica : Atenei Parmensis · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Right ventricular failure in congenital heart disease.Current opinion in pediatrics · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gunnar ErikssenACHD Unit, Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Jamil AboulhosnAhmanson/UCLA Adult Congenital Heart Disease Center, UCLA Medical Plaza, Los Angeles, California, USA.
Jeannette LinAhmanson/UCLA Adult Congenital Heart Disease Center, UCLA Medical Plaza, Los Angeles, California, USA.
Knut LiestølDepartment of Informatics, University of Oslo, Oslo, Norway.
Mette E EstensenACHD Unit, Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Ola GjesdalACHD Unit, Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Helge SkulstadFaculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Gaute DøhlenDepartment of Pediatric Cardiology, Oslo University Hospital, Oslo, Norway.
Harald Lauritz LindbergDepartment of Thoracic Surgery, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Patients with univentricular hearts (UVH) have high mortality despite modern treatment, and better methods to identify patients at highest risk are needed. We wanted to improve risk stratification in patients with UVH by focusing on the prognostic significance of single right versus single left ventricular morphology (SRV vs SLV). Methods: All 395 patients with UVH operated at our centre were prospectively included from 1972 to 2016 (195 SRV, 166 SLV, 34 mixed or indeterminate ventricular morphology). Diagnoses, UVH morphology, types of all operations and time and causes of death or heart transplantation (HTX) were recorded. The primary endpoint was death or HTX. Results: Among the 111 non-Fontan patients, 88 died (SRV 62 vs SLV 20; p<0.0001), 32 due to heart failure (SRV 23 vs SLV 5; p=0.0012). Twenty-five  years of cumulative SRV versus SLV survival among the 284 Fontan patients (41 deaths/HTX) was 66.9% vs 87.9% (p=0.0027), partly explained by more deaths/HTX due to heart failure among patients with SRV (p=0.0006). Survival in patients with SRV with and without hypoplastic left heart syndrome (HLHS) was similar. SRV versus SLV was a strong predictor of death/HTX in multivariable proportional hazards analyses (RR 3.3, 95% CI 1.6 to 6.6). Conclusion: SRV versus SLV is a strong short-term and long-term predictor of survival among patients with UVH, mainly explained by higher rates of death/HTX due to heart failure in the SRV group. Our findings apply to patients with SRV both with and without HLHS.

Indexed as

congenital heart defectsheart surgerysurvivaluniventricular heartsventricular morphology

Identifiers

PMID30364544
PMCPMC6196969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.